The gonadotropin-releasing hormone agonist leuprolide acetate induces apoptosis and suppresses cell proliferative activity in rectovaginal endometriosis

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 3, 1999, Pages 750-751

  Mizutani, Takahiro ^a   Sugihara, Ayako ^c   Nakamuro, Karo ^b   Suehara, Noriyuki ^a   Terada, Nobuyuki ^c  

^a Osaka Med Ctr Res Inst M   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Add back therapy; Apoptosis; Endometriosis; Gonadotropin releasing hormone agonist; Ki 67

Indexed keywords

GONADORELIN AGONIST; KI 67 ANTIGEN; LEUPRORELIN;

APOPTOSIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECTOUTERINE POUCH; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032853270     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70523-5     Document Type: Article

References (2)

1. 1. Mizutani T, Sugihara A. Nakamuro K, Nobuyuki T. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin releasing hormone agonist (leuprolide acetate). J Clin Endocrinol Metab 1998;83:1253-5.
2. 2. Schweppe K-W, Wynn RM, Beller FK. Ultrastructural comparison of endometriotic implants and eutopic endometrium. Am J Obstet Gynecol 1984;148:1024-39.